Search details
1.
Prevention and treatment of papillomavirus-related cancers through immunization.
Annu Rev Immunol
; 29: 111-38, 2011.
Article
in English
| MEDLINE | ID: mdl-21166538
2.
Metabolomics at the tumor microenvironment interface: Decoding cellular conversations.
Med Res Rev
; 44(3): 1121-1146, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38146814
3.
Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment.
Blood
; 136(26): 3004-3017, 2020 12 24.
Article
in English
| MEDLINE | ID: mdl-32818230
4.
Investigating T Cell Immunity in Cancer: Achievements and Prospects.
Int J Mol Sci
; 22(6)2021 Mar 12.
Article
in English
| MEDLINE | ID: mdl-33809369
5.
Galectin-1 is associated with poor prognosis in patients with cutaneous head and neck cancer with perineural spread.
Cancer Immunol Immunother
; 65(2): 213-22, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26759008
6.
Control of B-cell lymphoma by therapeutic vaccination and acquisition of immune resistance is independent of direct tumour IFN-gamma signalling.
Immunol Cell Biol
; 94(6): 554-62, 2016 07.
Article
in English
| MEDLINE | ID: mdl-26786233
7.
HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells.
PLoS Pathog
; 10(10): e1004466, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25340820
8.
Recent progress in vaccination against human papillomavirus-mediated cervical cancer.
Rev Med Virol
; 25 Suppl 1: 54-71, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25752816
9.
Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Immunol Rev
; 239(1): 85-98, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-21198666
10.
A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin.
J Immunol
; 189(12): 5622-31, 2012 Dec 15.
Article
in English
| MEDLINE | ID: mdl-23144496
11.
NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins.
J Immunol
; 187(4): 1601-8, 2011 Aug 15.
Article
in English
| MEDLINE | ID: mdl-21742969
12.
Histone deacetylase inhibitors in the generation of the anti-tumour immune response.
Immunol Cell Biol
; 90(1): 33-8, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-22064708
13.
Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production.
J Immunol
; 184(3): 1242-50, 2010 Feb 01.
Article
in English
| MEDLINE | ID: mdl-20028654
14.
Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen.
J Immunol
; 184(10): 5663-9, 2010 May 15.
Article
in English
| MEDLINE | ID: mdl-20410490
15.
Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses.
Proc Natl Acad Sci U S A
; 106(20): 8314-9, 2009 May 19.
Article
in English
| MEDLINE | ID: mdl-19416823
16.
IFN-gamma promotes generation of IL-10 secreting CD4+ T cells that suppress generation of CD8 responses in an antigen-experienced host.
J Immunol
; 183(1): 51-8, 2009 Jul 01.
Article
in English
| MEDLINE | ID: mdl-19535638
17.
PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy.
Cancers (Basel)
; 13(13)2021 Jul 01.
Article
in English
| MEDLINE | ID: mdl-34282763
18.
Regulatory T Cells but Not IL-10 Impair Cell-Mediated Immunity in Human Papillomavirus E7+ Hyperplastic Epithelium.
J Invest Dermatol
; 141(5): 1264-1273.e3, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33129828
19.
Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4+CD25+ T cells.
Eur J Immunol
; 39(2): 481-90, 2009 Feb.
Article
in English
| MEDLINE | ID: mdl-19180468
20.
HPV vaccines: the beginning of the end for cervical cancer.
Curr Opin Immunol
; 19(2): 232-8, 2007 Apr.
Article
in English
| MEDLINE | ID: mdl-17293100